Wendall Wierenga

(Dr. Wendall Wierenga Ph.D.)

Currently holds positions in Concert Pharmaceuticals Inc, Santarus Inc, Crinetics Pharmaceuticals Inc, Onyx Pharmaceuticals Inc, XenoPort Inc and Cytokinetics Inc

Positions

Position Company Period
Director Concert Pharmaceuticals Inc March 13, 2014 -
Executive Vice President - Research and Development Santarus Inc June 20, 2011 -
Independent Chairman of the Board Crinetics Pharmaceuticals Inc Oct. 1, 2015 -
Independent Director Onyx Pharmaceuticals Inc Dec. 1, 1996 -
Independent Director XenoPort Inc Jan. 1, 2000 -
Independent Director Cytokinetics Inc Feb. 9, 2011 -
Independent Director Seelos Therapeutics Inc March 10, 2014 - Jan. 24, 2019
Independent Director Ocera Therapeutics Inc Dec. 19, 2013 - Dec. 11, 2017
Wendall Wierenga's trades of Cytokinetics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-16 2024-12-16
S Sale
742 -2.9%
48.61
USD 36,069 		742 -2.9% 48.61 USD 36,069
2024-11-26 2024-11-25
S Sale
742 -2.9%
50.00
USD 37,100 		742 -2.9% 50.00 USD 37,100
2024-10-31 2024-10-28
S Sale
4,452 -15.3%
52.25
USD 232,617 		4,452 -15.3% 52.25 USD 232,617
2023-12-27 2023-12-27
PS Planned sale
5,000 -21.1%
73.60
USD 368,000 		5,000 -21.1% 73.60 USD 368,000
2023-12-27 2023-12-27
PS Planned sale
5,000 -21.1%
73.60
USD 368,000 		5,000 -21.1% 73.60 USD 368,000
2023-08-21 2023-08-21
S Sale
6,020 -24.9%
32.02
USD 192,760 		6,020 -24.9% 32.02 USD 192,760
2023-02-08 2023-02-06
PS Planned sale
7,000 -35.8%
45.00
USD 315,000 		7,000 -35.8% 45.00 USD 315,000
2022-09-01 2022-09-01
PS Planned sale
4,166 -25.5%
52.79
USD 219,923 		4,166 -25.5% 52.79 USD 219,923
2020-04-29 2020-04-28
S Sale
6,666 -100.0%
16.00
USD 106,656 		6,666 -100.0% 16.00 USD 106,656
2020-04-29 2020-04-28
S Sale
3,333 -100.0%
16.00
USD 53,328 		3,333 -100.0% 16.00 USD 53,328
2014-10-24 2014-10-22
B Purchase
20,000 +inf%
1.52
USD 30,364 		20,000 +inf% 1.52 USD 30,364
// ... existing code ... // ... rest of the file ...